Medical Isotopes Market Report 2026

Medical Isotopes Market Overview

• Medical Isotopes market size has reached to $7.26 billion in 2025 • Expected to grow to $10.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rising Cancer And Heart Disease Rates Is Driving Forces Behind The Growth Of The Medical Isotope Market • Market Trend: Strategic Collaborations Drive Growth In The Medical Isotope Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Isotopes Market?

Medical isotopes are radioactive isotopes used in medical imaging, diagnosis, and therapy. They emit radiation that can be detected by imaging devices, providing vital information about biological processes in the body. Common examples include Technetium-99m for imaging and Iodine-131 for treating thyroid conditions. The main product type of medical isotopes includes stable isotopes, and radio isotopes. Stable isotopes are versions of chemical elements that do not decay over time, maintaining their atomic structure indefinitely. The production methods for medical isotopes include neutron activation, cyclotrons, nuclear reactors, and others. These isotopes are used in applications such as nuclear therapy, equipment radioactive sources, and diagnosis. The end users of medical isotopes are hospitals, diagnostic centers, and research institutes.

What Is The Medical Isotopes Market Growth Forecast?

The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $10.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising demand for targeted radiotherapy, investment in cyclotron infrastructure, growth of personalized medicine, technological advancements in isotope production methods. Major trends in the forecast period include rising use of radioisotopes in diagnostic imaging, growing adoption of nuclear medicine therapies, increasing demand for precision oncology treatments, expansion of cyclotron based isotope production, higher focus on short lived isotope supply chains.

Global Medical Isotopes Market Segmentation

1) By Product Type: Diagnostic Radioisotopes, Therapeutic Radioisotopes, Theranostic Radioisotopes 2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method 3) By Application: Diagnostic Imaging, Targeted Radionuclide Therapy, Brachytherapy, Radiopharmaceutical Research & Development 4) By End Use: Hospitals, Diagnostic Imaging Centers, Research Institutes Subsegments: 1) By Diagnostic Radioisotopes: Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Carbon-11, Other Diagnostic Radioisotopes 2) By Therapeutic Radioisotopes: Iodine-131, Lutetium-177, Yttrium-90, Strontium-89, Samarium-153, Actinium-225, Other Therapeutic Radioisotopes 3) By Theranostic Radioisotopes: Gallium-68 / Lutetium-177 Pairs, Copper-64 / Copper-67 Pairs, Iodine-123 / Iodine-131 Pairs, Scandium-44 / Scandium-47 Pairs, Terbium Isotope Pairs, Other Theranostic Radioisotopes

What Is The Driver Of The Medical Isotopes Market?

The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to the frequency of new cases and prevalence of these diseases within a population over a specified period, providing insights into public health trends and the effectiveness of preventive measures. The increasing prevalence of cancer and heart disease correlates with the widespread sedentary lifestyle encouraged by modern technology and desk-bound occupations, resulting in reduced levels of physical activity. Medical isotopes are used to diagnose and treat cancer and heart disease through imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans and therapies such as radiation therapy and radioactive stents. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, reported that in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising cancer and heart disease rates are driving the growth of the medical isotope industry.

What Is The Driver Of The Medical Isotopes Market?

The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to the frequency of new cases and prevalence of these diseases within a population over a specified period, providing insights into public health trends and the effectiveness of preventive measures. The increasing prevalence of cancer and heart disease correlates with the widespread sedentary lifestyle encouraged by modern technology and desk-bound occupations, resulting in reduced levels of physical activity. Medical isotopes are used to diagnose and treat cancer and heart disease through imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans and therapies such as radiation therapy and radioactive stents. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, reported that in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising cancer and heart disease rates are driving the growth of the medical isotope industry.

Global Medical Isotopes Market Trends and Insights

Major companies operating in the medical isotope market are focusing on strategic collaborations to gain a competitive edge in the market. Strategic collaboration is a formal agreement between two or more parties to work together toward achieving specific, predetermined goals that are mutually beneficial. For instance, in September 2023, International Isotopes Inc., a US-based medical technology company partnered with Phantech Medical, a US-based biomedical hardware company to integrate the solutions for customers. With this partnership, they aim to revolutionize the calibration and reference sources market for pre-clinical imaging by designing, manufacturing, and distributing innovative sealed sources for the medical imaging and theranostics communities.

What Are Latest Mergers And Acquisitions In The Medical Isotopes Market?

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biopharmaceutical company, acquired ARTMS Inc. for an undisclosed amount. Telix gains enhanced access to ARTMS' innovative radiopharmaceutical production technologies, strengthening its position in the development and commercialization of targeted radiopharmaceuticals for cancer imaging and therapy. ARTMS Inc. is a Canada-based medical equipment manufacturing company that develops technology that transforms the production of diagnostic imaging isotopes.

Regional Insights

North America was the largest region in the medical isotopes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Isotopes Market?

The medical isotopes market consists of sales of technetium-99m, carbon-11, and gallium-68 which serve specific purposes in medical diagnosis and therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Isotopes Market Report 2026?

The medical isotopes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical isotopes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.